Hikal Q3 FY26 Results: Revenue ₹4.94 Bn, Net Loss ₹59 Mn

Hikal Limited, a diversified player in the chemicals and pharmaceuticals industry, announced its December quarter (Q3 FY26) results. The company posted consolidated revenue from operations of ₹4.94 billion but reported a net loss of ₹59 million, reflecting sectoral headwinds and rising input costs.

Despite the loss, Hikal continues to emphasize operational efficiency, innovation, and strategic investments to strengthen its position in both domestic and international markets. The company remains committed to long-term growth through sustainable practices and product diversification.

Key Highlights

• Revenue Performance: Consolidated revenue from operations stood at ₹4.94 billion in Q3 FY26.
• Profitability: Net loss after tax reported at ₹59 million.
• Sectoral Presence: Strong footprint in chemicals and pharmaceuticals.
• Operational Challenges: Impacted by rising input costs and market volatility.
• Strategic Outlook: Focus on innovation, sustainability, and global expansion.

This performance underscores Hikal’s resilience and its commitment to balancing short-term challenges with long-term strategic investments in the pharma-chemicals sector.

Sources: CNBC-TV18, Mint, FilingReader Intelligence